Glyoxal is a superior fixative to formaldehyde in promoting antigenicity and structural integrity in murine cardiac tissues.

Saved in:
Bibliographic Details
Title: Glyoxal is a superior fixative to formaldehyde in promoting antigenicity and structural integrity in murine cardiac tissues.
Authors: Teng ACT; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Mehangrey D; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Vandenbelt A; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Vearncombe K; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Callahan JD; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.; Toronto General Hospital Research Institute, University Health Network, Canada., Mistry P; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.; Toronto General Hospital Research Institute, University Health Network, Canada., Li W; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Reitz CJ; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Hamed O; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Roche M; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Kuzmanov U; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada., Fish JE; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.; Toronto General Hospital Research Institute, University Health Network, Canada., Epelman S; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.; Toronto General Hospital Research Institute, University Health Network, Canada.; Department of Immunology, University of Toronto, Canada.; Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada., Gramolini AO; Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Canada.; Department of Physiology, University of Toronto, Canada.
Source: Journal of molecular and cellular cardiology plus [J Mol Cell Cardiol Plus] 2025 May 11; Vol. 12, pp. 100454. Date of Electronic Publication: 2025 May 11 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918470779706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-9761 (Electronic) Linking ISSN: 27729761 NLM ISO Abbreviation: J Mol Cell Cardiol Plus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-9761
DOI:10.1016/j.jmccpl.2025.100454